Companies › TOI

THE ONCOLOGY INSTITUTE INC (TOI)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001799191 · EDGAR filings · Updated 2026-07-22

THE ONCOLOGY INSTITUTE INC (TOI) has reported institutional ownership of 39.2%, with 115 institutional managers holding positions valued at $118.9M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-22 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-16 — Insider transaction reported (Form 4)
• 2026-07-14 — Notice of proposed sale filed (Form 144)
• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-09 — Insider transaction reported (Form 4)
• 2026-07-09 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, THE ONCOLOGY INSTITUTE INC has 115 institutional holders and institutional ownership of 39.2%.

Insider activity

Insiders reported 67 transactions (8 buys, 14 sells) across 16 reporting insiders, with a net reported value of −$32.4M.

Data flags from SEC filings

Related companies

CORBUS PHARMACEUTICALS HLDGS (CRBP) · Whitehawk Therapeutics Inc (WHWK) · AGILON HEALTH INC (AGL) · CLEARPOINT NEURO INC (CLPT) · INOGEN INC (INGN) · AIRSCULPT TECHNOLOGIES INC (AIRS)